New cholesterol combo shows promise in final trial
NCT ID NCT06955104
Summary
This completed Phase 3 trial tested whether giving two drugs together (JW0108 and C2407) is effective and safe for people with dyslipidemia, a condition of unhealthy cholesterol levels. The main goal was to see how much the treatment lowered 'bad' LDL cholesterol. The study involved 145 adults and was designed to provide clear evidence before potential approval.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.